Dextrose Injection Supply and Distribution

The contract involves the manufacture and delivery of one unit of Dextrose Injection, USP 5% in a 500 mL flexible container, specifically to meet the stringent regulatory and quality standards set by the FDA, current Good Manufacturing Practices, and military medical requirements. This procurement is managed by the Defense Logistics Agency under the Department of Defense, ensuring the product is suitable for use in military medical operations and complies with all federal and defense-specific pharmaceutical guidelines. The item is classified under NAICS code 325412, indicating it falls within pharmaceutical preparation manufacturing. The contract is structured as a subcontract and was posted on July 14, 2026, with performance obligations tied to the delivery and distribution timelines enforced by DLA. While specific delivery locations and point of contact details are not provided, the place of performance and organizational address information suggest nationwide or global logistical coordination as required for defense supply chains. The contract reference link confirms its official tracking through the DIBBS system, ensuring transparency and accountability in procurement execution for military healthcare needs.